Health Archive » July, 2008

Health - July, 2008

161 articles

• AstraZeneca Files 5th Suit Over Generic Seroquel
• Sepracor Suits Over Planned Generic Xyzal Pile Up
• Abbott Settles HIV Antitrust Suit With Indirect Buyers
• Ariz. Court Validates Bard's Graft Patent
• Abraxis Fails To Nix Naropin Suit Antitrust Claims
• FDA Warns Baxter On Hemophilia Drug Promotion
• Axis-Shield Settles Homocysteine Patent Dispute
• FDA Orders Stronger Warn Labels For Anemia Drugs
• Class Certification Denied In Express Scripts Suit
• Judge Knocks Down Schwarz's Claims In Miralex Case
• Buchanan Ingersoll Disqualified From Ritalin Suit
• Fed. Circ. Sides With Sanofi In Patent Spat With Novo
• Teva Settles Coreg Suit Against Dr. Reddy's
• FDA Seizes $24M In Unapproved Drugs From KV
• Riegel V. Medtronic: Better Off Without It?
• Judge Certifies Class In N.Y. Nursing Antitrust Suit
• German Court OKs Generic Plavix, Cos. To Appeal
• Endo Hits Impax With 3rd Suit Over Painkiller
• Judge Rejects New Notice For Digitek Patients
• Drug Cos. Win Big With Pass-On Defense
• Lawyers In Guidant Case Ask For Higher Fee
• Novartis Sues Teva Over Premature ANDA Letters
• 2nd Circ. Affirms FDA Injunction Decision
• Stent Inventor Sues Abbott For Infringement
• Seven Patents Dropped From GE Patent Battle
• EU Product Liability Directive's Statute Of Limitations
• Payout Rates Slashed For Litigators In Medtronic MDL
• Judge Tosses Preempted Claims From Aredia Suits
• LecTec Sticks J&J, Others With Medical Patch Suit
• Melnyk Drops Biovail Proxy Bid, For Now
• Opponents Of Gene Patents Fight On
• Biovail Dodges Antitrust Class Actions Over Tiazac
• Judge Cites Cert Grant In Keeping Lexapro Cases Alive
• Judge Dismisses Ortho-McNeil From One AWP Claim
• FTC Launches Formal Investigation Into Immucor
• Shire Sues Actavis Over Carbatrol ANDA
• PRP Breached Duty To Verex Shareholders: Jury
• AstraZeneca Sues Mylan Over Entocort ANDA
• Shareholder Sues Roche, Genentech Over $43.7B Deal
• Feds Seize Erectile Dysfunction Drugs
• Cephalon Sues Barr Over Generic Fentora
• Lawyers Debate Value Of 'Lone Pine' Orders
• Regulatory And Govt. Affairs Practice: WilmerHale
• Suit Alleges Teva's Pergolide Damaged Heart Valves
• Dechert Snags Former Tyco VP
• Sanofi Can't Subpoena Employers In Gender Suit
• Regulators Conclude Merck's Gardasil Is Safe
• GSK Snags Former FDA General Counsel Dan Troy
• Amerigroup Settles Discrimination Suit For $234M
• Monopoly Puts Pet Owners In Doghouse: Suit
• On Biotech Hot Streak, Roche Picks Up Arius
• Court Narrows Discovery In Gender Suit V. Kyphon
• Regulatory Practice: Fish & Richardson
• Judge Rejects KV Sanctions Bid In Ritalin ANDA Suit
• Portable Ultrasound Makers Settle Patent Dispute
• Boston, Medtronic Agree To Slash Damages By $64M
• FDA Warns Anika About 'Adulterated' Devices
• New Study Adds Vytorin Woes For Merck, Schering
• Biota, GSK Settle Relenza Marketing Suit For $19.5M
• Cox To Pay $60M For Kickbacks, Medicare Fraud
• Impax's Flomax ANDA Triggers Patent Suit
• Baxter Wins Judgment In Failure-To-Warn Case
• FTC, Virginia Hospitals' Attorney Debate Broken Deal
• Regulators To Take Close Look At Big Pharma Deals
• W.L. Gore Says Medtronic Patents Are Invalid
• Fed. Circ. Upholds Eisai's Aciphex Patent
• Bayer CropScience Faces 2 More Modified-Rice Suits
• Leiner Files Plan With Committee's OK
• Paxil Preemption Ruling Reversed In Indiana
• Merck's Vioxx Payouts To Begin In August
• Jury Clears J&J, Motrin For Girl's Blindness
• House To Probe FDA Knowledge Of Ranbaxy Fraud
• KV Sues Breckenridge Over Supplement Patent
• Ortho V. Mylan: Key Ruling For 2 Statutory Provisions
• Sanofi Stalls Generic Plavix Launch In Germany
• Fenwick Life Sciences Partner Jumps To Reed Smith
• S.C. Mayor Settles Insider Trading Suit With SEC
• Wyeth, Impax Settle Effexor Patent Dispute
• DEA's New Proposed Regulations For E-Prescribing
• Wyeth Reverses Course, Settles Prempro Suit
• Advanced Bionics Pays $1.1M To Settle With FDA
• Advanced Medical Optics Wins LASIK Patent Case
• Judge Orders New Biovail Shareholder Meeting
• Health Practice: Hogan & Hartson
• SmithKline Beecham Sued For Generic Flonase Delay
• N.J. Packagers Are Link In Acutrim Liability Chain
• Cos. Settle Dutch Probe Into Oil-For-Food For €1.3M
• DOJ Slow To Shield Lawyer-Client Privilege: Senator
• Fed. Circ. Rules Apotex's Fosamax Appeal Moot
• FDA Warns Avastin May Cause Anemia
• Fed. Circuit Remands Stent Case Over 'Ambiguity'
• New Study Hints At More Fosamax Problems
• Abbott, Hospira To Face Trial In ERISA Class Action
• By-Pass Sues Abbott Over Vascular Repair Patent
• Judge Gives Biotech Co. Shareholders 2nd Chance
• Firm Wants Higher Contingency Fee In Guidant MDL
• N.J. Court Dismisses Hormone Therapy Lawsuit
• Sides Bicker Over Bifurcation In Mirapex Case
• Judge Finalizes Last Warner Chilcott Settlement
• AstraZeneca Files Ninth Suit Over Crestor Patent
• Judge Partly Reverses $250M Verdict For Medtronic
• Amgen Agrees To $200M Settlement Of Antitrust Suit
• Ranbaxy Denies DOJ Allegations Over Audits
• Cases Added To MDL Over Tainted Heparin
• Actavis Hit With Class Action Over Digitek
• Emergent Sues Protein Sciences Over Failed Deal
• Roche, Ranbaxy Patent Fight Can Go To Trial
• Medical Tourism: U.S. Providers Weigh In
• The Last Word On Drug Preemption?
• Transkaryotic Ex-CEO Settles SEC Suit For $1.2M
• Corepharma Counterclaim Restored To Carbatrol Suit
• Abbott Labs Strikes Again Over Depakote ER
• House Of Lords Validates Angiotech's Stent Patent
• Suit Claims Botox Caused Injuries, Deaths
• Health Practice: McDermott, Will & Emery
• Pharmaceutical Industry Revises Code Of Conduct
• No Proven Links Between Eczema Drug, Cancer: Judge
• Biolitec Attacks VNUS' Laser Treatment Patents
• Apotex Acular ANDA Infringes Roche: Fed. Circ.
• MediCor Receives Fourth Exclusivity Extension
• Boston Scientific Bid For New Stent Trial Rejected
• Pfizer Forgoes Fees To Close Accupril Suit
• Judge Lifts Stay Of Counterclaims In Ofloxacin Case
• SEC Sues Two In 'Pump And Dump' Scheme
• Efforts To Curb Arbitration Are Gaining Momentum
• Judge Tosses $27M Award In Prempro Case
• Celgene Sues Barr Again Over Cancer Drug
• FDA Urges Warning For Cipro, Other Antimicrobials
• McDermott Fights St. Vincent's Claims Over Fees
• Molecular Samples Tester Sued Over Assay Patents
• Bristol-Myers Agrees To Clean Air Act Upgrades
• Abbott Loses Appeal Bid In HIV Drug Litigation
• Karl Storz Sues FemSuite Over Endoscope Patent
• California Blue Cross To Pay $11.8M Settlement
• 3rd Circ. Asks Pa. High Court To Mull 'In Pari Delicto'
• 3rd Circuit Affirms Dismissal Of Savient Class Action
• Judge Inclined To OK Zyprexa Class, Urges Settling
• Shire Sues Apotex, Nostrum Over Carbatrol ANDAs
• 6th Circ. Reverses Race Bias Ruling In Baxter Suit
• VNUS Sues Three More Rivals Over Laser Treatment
• Pfizer Employee Avoids Prison in Embezzlement Case
• Sheppard Adds Two IP Litigators To Its Ranks
• Michigan Contests BCBS For-Profit Acquisition
• Daiichi Sankyo's Patent Suits V. Mylan Combined
• Panel Recommends More Testing for Diabetes Drugs
• In Light Of Whole Foods, Inova Backlash Insignficant
• Eli Lilly Drops Glenmark In $500M ADHD Drug Suit
• Governor Files Amicus Brief In DuPont Appeal
• 6th Circ. Vacates Ruling In $2B National Century Case
• Bone Fusing Products Pose Risk, FDA Says
• UnitedHealth To Settle Options Battles For $912M
• Jury Lets One Fen-Phen Lawyer Off The Hook
• Inequitable Conduct Claim Nixed In Seroquel Suit
• Pfizer Wins Dismissal Of 4 Claims From Celebrex Suit
• Drugmakers To Appeal $114M Verdict In AWP Case
• Bavarian Nordic Sues Oxford BioMedica Over Patents
• Biotech Cos. Battle Over Forum In Stem Cells Suit
• VA Official Pleads Guilty To Accepting Kickbacks
• CORRECTED: Cardio Access Expands Catheter Patent Suit
• AstraZeneca Sues To Protect Accolate
• Plaintiffs Battle For Lead Role In Vytorin ERISA Suit